Rhinorrhea, cough and fatigue in patients taking sitagliptin
<p>Abstract</p> <p>Sitagliptin is a dipeptidyl peptidase-4 (DPP IV, CD26) inhibitor indicated for treatment of Type II diabetes as a second line therapy after metformin. We report fifteen sitagliptin intolerant patients who developed anterior and posterior rhinorrhea, cough, dyspne...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2010-05-01
|
| Series: | Allergy, Asthma & Clinical Immunology |
| Online Access: | http://www.aacijournal.com/content/6/1/8 |